MELANOMA, UVEAL

Clinical trials for MELANOMA, UVEAL explained in plain language.

Never miss a new study

Get alerted when new MELANOMA, UVEAL trials appear

Sign up with your email to follow new studies for MELANOMA, UVEAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Immune cell therapy shows promise against rare eye cancer

Disease control Ongoing

This phase 2 trial tests whether a patient's own immune cells, called tumor-infiltrating lymphocytes (TIL), can shrink tumors in people with metastatic uveal melanoma, a rare and aggressive eye cancer. Participants receive chemotherapy to prepare their immune system, then an infu…

Matched conditions: MELANOMA, UVEAL

Phase: PHASE2 • Sponsor: Udai Kammula • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC

MELANOMA, UVEAL

Get alerted when new MELANOMA, UVEAL trials appear

Immune cell therapy shows promise against rare eye cancer